• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1-ETO 缺失导致 t(8;21) AML 中增强子-启动子相互作用发生 C/EBPα 和 AP-1 介导的改变。

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

机构信息

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B152TT, UK.

Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.

出版信息

Cell Rep. 2019 Sep 17;28(12):3022-3031.e7. doi: 10.1016/j.celrep.2019.08.040.

DOI:10.1016/j.celrep.2019.08.040
PMID:31533028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6899442/
Abstract

Acute myeloid leukemia (AML) is associated with mutations in transcriptional and epigenetic regulator genes impairing myeloid differentiation. The t(8;21)(q22;q22) translocation generates the RUNX1-ETO fusion protein, which interferes with the hematopoietic master regulator RUNX1. We previously showed that the maintenance of t(8;21) AML is dependent on RUNX1-ETO expression. Its depletion causes extensive changes in transcription factor binding, as well as gene expression, and initiates myeloid differentiation. However, how these processes are connected within a gene regulatory network is unclear. To address this question, we performed Promoter-Capture Hi-C assays, with or without RUNX1-ETO depletion and assigned interacting cis-regulatory elements to their respective genes. To construct a RUNX1-ETO-dependent gene regulatory network maintaining AML, we integrated cis-regulatory element interactions with gene expression and transcription factor binding data. This analysis shows that RUNX1-ETO participates in cis-regulatory element interactions. However, differential interactions following RUNX1-ETO depletion are driven by alterations in the binding of RUNX1-ETO-regulated transcription factors.

摘要

急性髓细胞白血病(AML)与转录和表观遗传调节基因的突变有关,这些突变会损害髓系分化。t(8;21)(q22;q22)易位产生 RUNX1-ETO 融合蛋白,该蛋白干扰造血主调控因子 RUNX1。我们之前表明,t(8;21)AML 的维持依赖于 RUNX1-ETO 的表达。其耗竭会导致转录因子结合以及基因表达的广泛变化,并启动髓系分化。然而,这些过程在基因调控网络中是如何联系的尚不清楚。为了解决这个问题,我们进行了启动子捕获 Hi-C 分析,有或没有 RUNX1-ETO 的耗竭,并将相互作用的顺式调节元件分配给它们各自的基因。为了构建维持 AML 的 RUNX1-ETO 依赖性基因调控网络,我们将顺式调节元件相互作用与基因表达和转录因子结合数据进行了整合。该分析表明,RUNX1-ETO 参与顺式调节元件的相互作用。然而,RUNX1-ETO 耗竭后差异相互作用是由 RUNX1-ETO 调节的转录因子结合的改变驱动的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/39149d7e6374/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/48583ee60b4f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/91385518a4ee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/0a4c7dcf3294/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/53dbf705521f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/39149d7e6374/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/48583ee60b4f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/91385518a4ee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/0a4c7dcf3294/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/53dbf705521f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fce/6899442/39149d7e6374/gr4.jpg

相似文献

1
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.RUNX1-ETO 缺失导致 t(8;21) AML 中增强子-启动子相互作用发生 C/EBPα 和 AP-1 介导的改变。
Cell Rep. 2019 Sep 17;28(12):3022-3031.e7. doi: 10.1016/j.celrep.2019.08.040.
2
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.t(8;21)AML 细胞中 RUNX1/ETO 的耗竭导致染色质结构和转录因子结合的全基因组变化。
Leukemia. 2012 Aug;26(8):1829-41. doi: 10.1038/leu.2012.49. Epub 2012 Feb 20.
3
RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia.RUNX1/ETO 和突变型 KIT 均有助于编程 t(8;21) 急性髓系白血病中的转录和染色质景观。
Exp Hematol. 2020 Dec;92:62-74. doi: 10.1016/j.exphem.2020.10.005. Epub 2020 Nov 2.
4
AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.AML1/ETO 通过启动子和内含子增强子之间的远程相互作用反式激活 c-KIT 表达。
J Cell Biochem. 2018 Apr;119(4):3706-3715. doi: 10.1002/jcb.26587. Epub 2018 Jan 5.
5
The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.造血转录因子RUNX1和ERG可防止t(8;21)急性髓系白血病(AML)中AML1-ETO致癌基因的过度表达及凋亡程序的启动。
Cell Rep. 2016 Nov 15;17(8):2087-2100. doi: 10.1016/j.celrep.2016.08.082.
6
An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.一种AML1-ETO/miR-29b-1调控回路调节急性髓系白血病细胞的表型特性。
Oncotarget. 2017 Jun 20;8(25):39994-40005. doi: 10.18632/oncotarget.18127.
7
The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.致白血病的t(8;21)融合蛋白AML1-ETO控制核糖体RNA基因,并与有丝分裂染色体上的核仁组织区相关联。
J Cell Sci. 2008 Dec 1;121(Pt 23):3981-90. doi: 10.1242/jcs.033431. Epub 2008 Nov 11.
8
Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1.伴有t(8;21)(q22;q22.1);RUNX1-RUNX1T1的残留急性髓系白血病中的鲑鱼色颗粒。
Br J Haematol. 2021 May;193(4):691. doi: 10.1111/bjh.17307. Epub 2021 Jan 2.
9
Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.全基因组研究鉴定出 t(8;21) 急性髓系白血病中 AML1 和 AML1/ETO 之间的新型相互作用。
Blood. 2016 Jan 14;127(2):233-42. doi: 10.1182/blood-2015-03-626671. Epub 2015 Nov 6.
10
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.血小板生成素/MPL 通过 PI3K/AKT 信号参与启动和维持 RUNX1-ETO 急性髓系白血病。
Blood. 2012 Jul 26;120(4):868-79. doi: 10.1182/blood-2012-03-414649. Epub 2012 May 21.

引用本文的文献

1
JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells.JMJD1C形成凝聚物以促进多种类型AML细胞共有的依赖RUNX1的基因表达程序。
Protein Cell. 2025 May 28;16(5):338-364. doi: 10.1093/procel/pwae059.
2
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth.白血病干细胞激活谱系异常的信号通路以促进其生长。
Nat Commun. 2024 Feb 14;15(1):1359. doi: 10.1038/s41467-024-45691-4.
3
Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.

本文引用的文献

1
The AP-1 transcriptional complex: Local switch or remote command?AP-1 转录复合物:局部开关还是远程指令?
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):11-23. doi: 10.1016/j.bbcan.2019.04.003. Epub 2019 Apr 26.
2
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.致癌转录因子RUNX1/ETO破坏细胞周期调控以驱动白血病转化。
Cancer Cell. 2019 Apr 15;35(4):705. doi: 10.1016/j.ccell.2019.03.012.
3
Subtype-specific regulatory network rewiring in acute myeloid leukemia.
联合依利替康 B 和高三尖杉酯碱对 t(8;21) AML 发挥协同抗肿瘤作用。
Acta Pharmacol Sin. 2024 Mar;45(3):633-645. doi: 10.1038/s41401-023-01196-2. Epub 2023 Nov 28.
4
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.双重内含子靶向 CRISPR-Cas9 介导的 AML RUNX1-RUNX1T1 融合基因敲除有效抑制体外和体内肿瘤的增殖并减小肿瘤体积。
Leukemia. 2023 Sep;37(9):1792-1801. doi: 10.1038/s41375-023-01950-9. Epub 2023 Jul 18.
5
A RUNX1/ETO-SKP2-CDKN1B axis regulates expression of telomerase in t (8;21) acute myeloid leukemia.RUNX1/ETO-SKP2-CDKN1B 轴调节 t(8;21) 急性髓系白血病中端粒酶的表达。
Cell Mol Life Sci. 2023 Feb 23;80(3):70. doi: 10.1007/s00018-023-04713-y.
6
A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation.AML1-ETO与ETO2-GLIS2白血病融合蛋白之间的直接比较揭示了靶基因的上下文依赖性结合与调控以及在细胞分化中的相反功能。
Front Cell Dev Biol. 2022 Sep 7;10:992714. doi: 10.3389/fcell.2022.992714. eCollection 2022.
7
[Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].[t(8;21)急性髓系白血病中N6-甲基腺苷修饰模式的特征]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):690-697. doi: 10.12122/j.issn.1673-4254.2022.05.09.
8
In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of in suppressing early leukemic transformation.体内急性早幼粒细胞白血病进展的时间分辨率揭示了 在抑制早期白血病转化中的作用。
Genes Dev. 2022 Apr 1;36(7-8):451-467. doi: 10.1101/gad.349115.121. Epub 2022 Apr 21.
9
Modelling t(8;21) acute myeloid leukaemia - What have we learned?对t(8;21)急性髓系白血病的建模——我们学到了什么?
MedComm (2020). 2020 Sep 24;1(3):260-269. doi: 10.1002/mco2.30. eCollection 2020 Dec.
10
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.PLCG1 对于 AML1-ETO 白血病干细胞自我更新是必需的。
Blood. 2022 Feb 17;139(7):1080-1097. doi: 10.1182/blood.2021012778.
急性髓系白血病中亚型特异性调控网络重排。
Nat Genet. 2019 Jan;51(1):151-162. doi: 10.1038/s41588-018-0270-1. Epub 2018 Nov 12.
4
C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia.C/EBPα 可逆转急性髓系白血病中致癌转录因子的表观遗传重编程。
Blood Adv. 2018 Feb 13;2(3):271-284. doi: 10.1182/bloodadvances.2017012781.
5
Chromatin Structure Profiling Identifies Crucial Regulators of Tumor Maintenance.染色质结构分析确定肿瘤维持的关键调节因子。
Trends Cancer. 2015 Nov;1(3):157-160. doi: 10.1016/j.trecan.2015.10.003. Epub 2015 Nov 5.
6
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.RUNX1-ETO和RUNX1-EVI1在t(8;21)和t(3;21)急性髓系白血病中对染色质景观进行差异性重编程。
Cell Rep. 2017 May 23;19(8):1654-1668. doi: 10.1016/j.celrep.2017.05.005.
7
GOTHiC, a probabilistic model to resolve complex biases and to identify real interactions in Hi-C data.GOTHiC,一种用于解决复杂偏差并识别Hi-C数据中真实相互作用的概率模型。
PLoS One. 2017 Apr 5;12(4):e0174744. doi: 10.1371/journal.pone.0174744. eCollection 2017.
8
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.谱系特异性和单细胞染色质可及性图谱描绘了人类造血作用和白血病的演变。
Nat Genet. 2016 Oct;48(10):1193-203. doi: 10.1038/ng.3646. Epub 2016 Aug 15.
9
MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.MEIS2 是 AML1-ETO 阳性 AML 的致癌伙伴。
Cell Rep. 2016 Jul 12;16(2):498-507. doi: 10.1016/j.celrep.2016.05.094. Epub 2016 Jun 23.
10
On TADs and LADs: Spatial Control Over Gene Expression.关于 TADs 和 LADs:基因表达的空间控制。
Trends Genet. 2016 Aug;32(8):485-495. doi: 10.1016/j.tig.2016.05.004. Epub 2016 Jun 13.